Healthcare Biz Cheat Sheet: Novavax Wins $1.3M Government Contract; Forest Labs, BioCryst Drugs Get Results

Read Trending Stories

Today's Trending Stocks

Click a Company to Research Now:

Novavax (NASDAQ:NVAX) is trading higher after winning a $1.3 million contract from the U.S. Department of Homeland Security to develop a virus-like particle vaccine to protect against foot-and-mouth disease.

Hot Feature: Is the 2008 Bear Market Back?

BioCryst Pharmaceuticals (NASDAQ:BCRX) has announced positive-top line results for a Phase 2 study of its gout treatment, meeting its goal for the drug.

Forest Laboratories (NYSE:FRX) says preliminary results from a clinical trial of its experimental anti-psychotic drug Cariprazine showed improvement of bipolar mania symptoms compared to a placebo.

Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!

Do You Want More Profits? Wall St. Cheat Sheet Premium newsletter subscribers have been crushing the markets with winning stock picks.

Click here now for your FREE trial to our acclaimed flagship newsletter:

Learn More

Advertisement:
Improve your Investing Portfolio with Wall St Cheat Sheet Premium

Intelligent Investing

Wall St. Cheat Sheet Premium

Tired of wasting time and money sifting through the noise on TV, websites, and Twitter? Get winning stock picks now.

Gold & Silver Premium

Join Chicago Mercantile Exchange commentator Eric McWhinnie as he covers Gold & Silver for you.

Commodities Premium

Commodities are heating up. This is an investment newsletter you'll need to win in the bull market.

Wall St. Cheat Sheet has been featured in these fine media outlets: